Aleafia Health Posts 2018 Q3 Financial Results

- November 26th, 2018

Aleafia Health announced its Q3 fiscal results for the year 2018 securing C$1.6 million in revenue.

Aleafia Health (TSXV:ALEF) announced its Q3 fiscal results for the year 2018 securing C$1.6 million in revenue.

As quoted in the press release:

Q3 Financial Highlights:

  • Total revenue for the three and nine months ending September 30, 2018 was $1.6 million and $3 million, respectively. Q3 2018 revenue was up 36 per cent over Q2 2018.
  • Gross profit for the three and nine months ending September 30, 2018 was $2.2 million and $3.1 million, respectively.
  • For the Health & Wellness division, Q3 2018 revenue and operating income before non-cash items was $1.06 million and $206,458, respectively.
  • For the Farms & Products division, Q3 2018 revenue and operating income before non-cash items was $529,146 and $217,358, respectively. This included the sale of the company’s first harvest.
  • As of September 30, 2018, the Company had $22.8 million in cash on hand.

“As the company has achieved a number of important milestones, we are extremely encouraged by our third quarter results. It has been a transformative period for Aleafia. Our first cannabis sale marks the beginning of our cultivation expansion with Aleafia producing 98,000 [kilograms] of dried flower on an annual run rate basis,” said Aleafia Chairman Julian Fantino. “We look forward to soon supplying our growing base of over 50,000 patients with Aleafia-produced medical cannabis.”

Click here to read the full press release.

Get the latest Cannabis Investing stock information

Get the latest information about companies associated with Cannabis Investing Delivered directly to your inbox.

Cannabis Investing

Select All
Select None

Leave a Reply

Your email address will not be published. Required fields are marked *